isradipine has been researched along with Adenoma, Prostatic in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenthal, E | 1 |
| Shapiro, E | 1 |
| Lepor, H | 1 |
1 other study available for isradipine and Adenoma, Prostatic
| Article | Year |
|---|---|
Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
Topics: Binding Sites; Calcium Channel Blockers; Calcium Channels; Humans; In Vitro Techniques; Isradipine; | 1990 |